You are here

Article Text

Article menu
Download PDFPDF
Letters
PostScript
Concerns about the new NICE guidelines on intrapartum care and diabetes in pregnancy
  1. J R Fernandez,
  2. N Aiton,
  3. P Amess,
  4. R Bomont,
  5. C Lawn,
  6. P Seddon,
  7. R Watkins,
  8. H Rabe
  1. Department of Neonatology, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
  1. J R Fernandez, Department of Neonatology, Brighton and Sussex University Hospitals NHS Trust, Eastern Road, Brighton BN2 5BE, UK; joseramon.fernandez-alvarez{at}bsuh.nhs.uk

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We are pleased to see the two new National Institute for Health and Clinical Excellence (NICE) guidelines on intrapartum care and diabetes in pregnancy. However, we would like to highlight some areas of concern.

    The intrapartum care guideline (CG55) applies to mothers with premature rupture of membranes (PROM) (>24 h). Unfortunately it does not take into account maternal group B streptococcus (GBS) status. In most women in the UK, GBS status will be unknown, but up to 25% may be carriers. According to the new NICE guideline, mothers will not receive antibiotics before delivery unless there are signs of chorioamnionitis. The …

    View Full Text

    Footnotes

    • Competing interests: None declared.